Starting treatment
Step 1 of the All-Wales Adult Asthma Management and Prescribing Guideline provides an overview of inhaled therapies that are applicable to patients with a new diagnosis of asthma, and those patients with mild, intermittent asthma. Contrary to former Asthma Management Guidelines, short-acting Beta-agonists (monotherapy) is not an effective treatment option for this patient group, or any patients with asthma.
Instead, initiate therapy with regular low dose inhaled corticosteroids with short acting beta-agonist PRN.
In this Tutorial, Dr Katie Pink explores this Step further.
Starting treatment
Step 1 of the All-Wales Adult Asthma Management and Prescribing Guideline provides an overview of inhaled therapies that are applicable to patients with a new diagnosis of asthma, and those patients with mild, intermittent asthma. Contrary to former Asthma Management Guidelines, short-acting Beta-agonists (monotherapy) is not an effective treatment option for this patient group, or any patients with asthma.
Instead, initiate therapy with regular low dose inhaled corticosteroids with short acting beta-agonist PRN.
In this Tutorial, Dr Katie Pink explores this Step further.
Resources
 |
|---|
All Wales Adult Asthma Management and Prescribing Guideline
Endorsed by the Respiratory Health Implementation Group (RHIG), the All-Wales Adult Asthma Management guideline standardises management of patients with Asthma. The aim of this Guideline is to provide patients with asthma with basic asthma care, in line with the Personal Asthma Action Plan, and monitor preventer and reliever inhaler prescribing.
